Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms [Seeking Alpha]
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Yahoo! Finance]
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Globe and Mail, The (Toronto, Canada)]
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum [Yahoo! Finance]
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was given a new $16.00 price target on by analysts at Leerink Partners.